Breast Cancer Survivors Who Experience Aromatase Inhibitor Associated Musculoskeletal Symptoms (AIMSS)

Inclusion Criteria: * Patients are 18 years old or more. * A breast cancer survivor ECOG =\< 2, stage 0-III HR+ who is experiencing musculoskeletal symptoms associated with aromatase inhibitors intake * Patients must be at least 6 months on aromatase inhibitors and for no more than 7 years Exclusion Criteria: * Breast cancer survivor patients that are not in aromatase inhibitor treatment or have less than 6 months of treatment or more than 7 years of treatment. * Asymptomatic patients * Patients less than 18 years old * Patient that are not being followed as a Mayo Clinic patient * Patients with stage IV breast carcinoma * Patients that are HR - * Patients that are ECOG 3 or more